Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64,299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice.
Wu X, Guo J, Niu M, An M, Liu L, Wang H, Jin X, Zhang Q, Lam KS, Wu T, Wang H, Wang Q, Du Y, Li J, Cheng L, Tang HY, Shang H, Zhang L, Zhou P, Chen Z. Wu X, et al. Among authors: zhang l, zhang q. J Clin Invest. 2018 Jun 1;128(6):2239-2251. doi: 10.1172/JCI96764. Epub 2018 Apr 23. J Clin Invest. 2018. PMID: 29461979 Free PMC article.
Potent neutralizing monoclonal antibodies against Ebola virus infection.
Zhang Q, Gui M, Niu X, He S, Wang R, Feng Y, Kroeker A, Zuo Y, Wang H, Wang Y, Li J, Li C, Shi Y, Shi X, Gao GF, Xiang Y, Qiu X, Chen L, Zhang L. Zhang Q, et al. Among authors: zhang l. Sci Rep. 2016 May 16;6:25856. doi: 10.1038/srep25856. Sci Rep. 2016. PMID: 27181584 Free PMC article.
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies.
Yan R, Wang R, Ju B, Yu J, Zhang Y, Liu N, Wang J, Zhang Q, Chen P, Zhou B, Li Y, Shen Y, Zhang S, Tian L, Guo Y, Xia L, Zhong X, Cheng L, Ge X, Zhao J, Wang HW, Wang X, Zhang Z, Zhang L, Zhou Q. Yan R, et al. Among authors: zhang l, zhang s, zhang q, zhang z, zhang y. Cell Res. 2021 May;31(5):517-525. doi: 10.1038/s41422-021-00487-9. Epub 2021 Mar 17. Cell Res. 2021. PMID: 33731853 Free PMC article.
Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
Li M, Guo J, Lu S, Zhou R, Shi H, Shi X, Cheng L, Liang Q, Liu H, Wang P, Wang N, Wang Y, Fu L, Xing M, Wang R, Ju B, Liu L, Lau SY, Jia W, Tong X, Yuan L, Guo Y, Qi H, Zhang Q, Huang Z, Chen H, Zhang Z, Chen Z, Peng X, Zhou D, Zhang L. Li M, et al. Among authors: zhang l, zhang q, zhang z. Front Immunol. 2021 Jun 28;12:697074. doi: 10.3389/fimmu.2021.697074. eCollection 2021. Front Immunol. 2021. PMID: 34262569 Free PMC article.
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.
Shan S, Mok CK, Zhang S, Lan J, Li J, Yang Z, Wang R, Cheng L, Fang M, Aw ZQ, Yu J, Zhang Q, Shi X, Zhang T, Zhang Z, Wang J, Wang X, Chu JJH, Zhang L. Shan S, et al. Among authors: zhang l, zhang s, zhang q, zhang t, zhang z. Front Immunol. 2021 Dec 13;12:766821. doi: 10.3389/fimmu.2021.766821. eCollection 2021. Front Immunol. 2021. PMID: 34966387 Free PMC article.
Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies.
Zhou D, Chan JF, Zhou B, Zhou R, Li S, Shan S, Liu L, Zhang AJ, Chen SJ, Chan CC, Xu H, Poon VK, Yuan S, Li C, Chik KK, Chan CC, Cao J, Chan CY, Kwan KY, Du Z, Lau TT, Zhang Q, Zhou J, To KK, Zhang L, Ho DD, Yuen KY, Chen Z. Zhou D, et al. Among authors: zhang l, zhang aj, zhang q. Cell Host Microbe. 2021 Apr 14;29(4):551-563.e5. doi: 10.1016/j.chom.2021.02.019. Epub 2021 Feb 25. Cell Host Microbe. 2021. PMID: 33657424 Free PMC article.
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry.
Ge J, Wang R, Ju B, Zhang Q, Sun J, Chen P, Zhang S, Tian Y, Shan S, Cheng L, Zhou B, Song S, Zhao J, Wang H, Shi X, Ding Q, Liu L, Zhao J, Zhang Z, Wang X, Zhang L. Ge J, et al. Among authors: zhang l, zhang s, zhang q, zhang z. Nat Commun. 2021 Jan 11;12(1):250. doi: 10.1038/s41467-020-20501-9. Nat Commun. 2021. PMID: 33431856 Free PMC article.
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.
Zhang Q, Ju B, Ge J, Chan JF, Cheng L, Wang R, Huang W, Fang M, Chen P, Zhou B, Song S, Shan S, Yan B, Zhang S, Ge X, Yu J, Zhao J, Wang H, Liu L, Lv Q, Fu L, Shi X, Yuen KY, Liu L, Wang Y, Chen Z, Zhang L, Wang X, Zhang Z. Zhang Q, et al. Among authors: zhang l, zhang s, zhang z. Nat Commun. 2021 Jul 9;12(1):4210. doi: 10.1038/s41467-021-24514-w. Nat Commun. 2021. PMID: 34244522 Free PMC article.
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.
Ji Y, Zhang Q, Cheng L, Ge J, Wang R, Fang M, Mucker EM, Chen P, Ma J, Zhang R, Li C, Hammond H, Baracco L, Holbrook M, Frieman M, Zhang Z, Wang X, Hooper JW, Zhang L, Zhu Q. Ji Y, et al. Among authors: zhang l, zhang r, zhang q, zhang z. Front Immunol. 2022 Sep 14;13:980435. doi: 10.3389/fimmu.2022.980435. eCollection 2022. Front Immunol. 2022. PMID: 36189212 Free PMC article.
64,299 results
You have reached the last available page of results. Please see the User Guide for more information.